Broker Revenue Forecasts For Fate Therapeutics, Inc. (NASDAQ:FATE) Are Surging Higher
Celebrations may be in order for Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The revenue foreca...